O aumento da proporção de idosos trouxe mudanças importantes no perfil de morbidade geral. Uma maior frequência de doenças crônicas faz com que a prescrição de medicamentos seja cada vez mais extensa e mais complexa nesta população. Estes aspectos, somados às variações farmacocinéticas e farmacodinâmicas relacionadas com a idade e à crescente medicalização, levam ao aumento do risco de problemas relacionados à farmacoterapia, tais como o uso de medicamentos potencialmente inapropriados (MPI) e correspondente aparecimento de reações adversas. Esta dissertação tem como objetivo avaliar o uso de MPI entre idosos brasileiros utilizando a Lista PRISCUS (2010). Os dados analisados são provenientes da Pesquisa Nacional de Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM), de caráter transversal e amostra probabilística populacional em municípios brasileiros urbanos. Neste estudo, foram analisadas as informações obtidas com a população de idosos (60 anos ou mais) (N=9.019). A variável independente foram os medicamentos utilizados por idosos com 60 anos ou mais. As variáveis intervenientes foram sexo, idade, escolaridade, nível econômico e região geográfica. Também foram analisadas as variáveis presença de doença crônica e médico que trata doença crônica. Uma análise multivariável foi realizada para identificar os fatores para o uso de medicamentos inapropriados. Do total de idosos, 18,1% utilizaram no mínimo um medicamento considerado potencialmente inapropriado, independente de dose, sendo que o grupo de medicamentos para o sistema nervoso correspondeu a 45,8%, sendo a amitriptilina a mais prevalente. O uso de medicamentos inapropriados foi maior em mulheres (20,4%), idosos com 80 anos ou mais (22,2%), idosos com nenhuma escolaridade (21,5%), nível econômico C (18,6%), região Sul do Brasil (22,4%), idosos com doença crônica (DC) (21,8%) e que tratavam a DC com mais de um médico (28%). De acordo com a análise multivariável, a variável que se mostrou associada à maior probabilidade para o uso de medicamentos inapropriados foi o aumento do número de medicamentos. Idosos que utilizam maior número de medicamentos simultaneamente (polifarmácia) têm maior probabilidade de terapia inapropriada. Com o intenso processo de envelhecimento, a tendência é aumentar a utilização de medicamentos na população. Programas de atenção ao idoso devem constar como prioridade dos órgãos públicos de saúde. / The proportion of aged has increased causing important changes in the general morbidity profile. A higher frequency of chronic diseases makes medications prescription more and more extensive and complex in this population. These aspects, coupled with pharmacokinetic and pharmacodynamic variations related to age and increasing medicalization, lead to an increased risk of problems related to the use of medications, such as the use of potentially inappropriate medications (PIM) and corresponding adverse reactions. This dissertation aims at evaluating the use of PIM among Brazilian elders using the PRISCUS List (2010). The analyzed data came from the National Survey of Access, Use and Promotion of the Rational Use of Medicines (PNAUM, in Portuguese), of transversal character and population probabilistic sample in urban Brazilian municipalities. In this study, the information obtained with the elderly population (60 years or more) (N=9.019) was analyzed. The independent variable was the medication used by the 60 years old people or older. The intervening variables were sex, age, schooling, economic level and geographic region. Also, it were analyzed the presence of chronic disease and the doctor who treats chronic disease. A multivariate analysis was performed to identify the risk factors for the use of inappropriate medications. Of the total aged, 18.1% used at least one medication considered to be potentially inappropriate, regardless of dose, and the group of medications for the nervous system corresponded to 45.8%, with amitriptyline being the most prevalent. The use of inappropriate medications was higher in women (20.4%), 80 years old people or older (22.2%), aged with no schooling (21.5%), economic level C (18.6%), South region of Brazil (22.4%), aged with chronic disease (CD) (21.8%) and who treated CD with more than one physician (28%). According to the multivariate analysis, the variable that was shown to be associated with the greatest probability for the use of inappropriate medications was the increase in the number of medications. Aged who use more medications at the same time are more likely to have inappropriate therapy. With the intense process of aging, the tendency is to increase the use of medications by the population. Aged care programs should be a priority of public health agencies.

O aumento da proporção de idosos trouxe mudanças importantes no perfil de morbidade geral. Uma maior frequência de doenças crônicas faz com que a prescrição de medicamentos seja cada vez mais extensa e mais complexa nesta população. Estes aspectos, somados às variações farmacocinéticas e farmacodinâmicas relacionadas com a idade e à crescente medicalização, levam ao aumento do risco de problemas relacionados à farmacoterapia, tais como o uso de medicamentos potencialmente inapropriados (MPI) e correspondente aparecimento de reações adversas. Esta dissertação tem como objetivo avaliar o uso de MPI entre idosos brasileiros utilizando a Lista PRISCUS (2010). Os dados analisados são provenientes da Pesquisa Nacional de Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM), de caráter transversal e amostra probabilística populacional em municípios brasileiros urbanos. Neste estudo, foram analisadas as informações obtidas com a população de idosos (60 anos ou mais) (N=9.019). A variável independente foram os medicamentos utilizados por idosos com 60 anos ou mais. As variáveis intervenientes foram sexo, idade, escolaridade, nível econômico e região geográfica. Também foram analisadas as variáveis presença de doença crônica e médico que trata doença crônica. Uma análise multivariável foi realizada para identificar os fatores para o uso de medicamentos inapropriados. Do total de idosos, 18,1% utilizaram no mínimo um medicamento considerado potencialmente inapropriado, independente de dose, sendo que o grupo de medicamentos para o sistema nervoso correspondeu a 45,8%, sendo a amitriptilina a mais prevalente. O uso de medicamentos inapropriados foi maior em mulheres (20,4%), idosos com 80 anos ou mais (22,2%), idosos com nenhuma escolaridade (21,5%), nível econômico C (18,6%), região Sul do Brasil (22,4%), idosos com doença crônica (DC) (21,8%) e que tratavam a DC com mais de um médico (28%). De acordo com a análise multivariável, a variável que se mostrou associada à maior probabilidade para o uso de medicamentos inapropriados foi o aumento do número de medicamentos. Idosos que utilizam maior número de medicamentos simultaneamente (polifarmácia) têm maior probabilidade de terapia inapropriada. Com o intenso processo de envelhecimento, a tendência é aumentar a utilização de medicamentos na população. Programas de atenção ao idoso devem constar como prioridade dos órgãos públicos de saúde. / The proportion of aged has increased causing important changes in the general morbidity profile. A higher frequency of chronic diseases makes medications prescription more and more extensive and complex in this population. These aspects, coupled with pharmacokinetic and pharmacodynamic variations related to age and increasing medicalization, lead to an increased risk of problems related to the use of medications, such as the use of potentially inappropriate medications (PIM) and corresponding adverse reactions. This dissertation aims at evaluating the use of PIM among Brazilian elders using the PRISCUS List (2010). The analyzed data came from the National Survey of Access, Use and Promotion of the Rational Use of Medicines (PNAUM, in Portuguese), of transversal character and population probabilistic sample in urban Brazilian municipalities. In this study, the information obtained with the elderly population (60 years or more) (N=9.019) was analyzed. The independent variable was the medication used by the 60 years old people or older. The intervening variables were sex, age, schooling, economic level and geographic region. Also, it were analyzed the presence of chronic disease and the doctor who treats chronic disease. A multivariate analysis was performed to identify the risk factors for the use of inappropriate medications. Of the total aged, 18.1% used at least one medication considered to be potentially inappropriate, regardless of dose, and the group of medications for the nervous system corresponded to 45.8%, with amitriptyline being the most prevalent. The use of inappropriate medications was higher in women (20.4%), 80 years old people or older (22.2%), aged with no schooling (21.5%), economic level C (18.6%), South region of Brazil (22.4%), aged with chronic disease (CD) (21.8%) and who treated CD with more than one physician (28%). According to the multivariate analysis, the variable that was shown to be associated with the greatest probability for the use of inappropriate medications was the increase in the number of medications. Aged who use more medications at the same time are more likely to have inappropriate therapy. With the intense process of aging, the tendency is to increase the use of medications by the population. Aged care programs should be a priority of public health agencies.

Abstract Background and Objective: An accurate medication history list is an integral part of the patient assessment at hospital admission. The objective of the study was to describe the frequency, type, and predictors of unintentional medication errors and to evaluate the quality of the clinical pharmacy services focusing on the acceptance of the recommendations made by the clinical pharmacist. Setting and methods: A descriptive study was conducted at two internal medicine wards at Baghdad Teaching Hospital in Iraq using Lund Integrated Medicines Management (LIMM)-based medication reconciliation. The study pharmacist conducted medication interviews for patients shortly after hospital admission to obtain the most accurate pre-admission medication history list. This list was compared with the medication list in the patient’s medical chart. Intended addition, withdrawal of a drug, or changes to the dose/ dosage form in the patient’s medical list was considered as medication discrepancies. However, medication discrepancies were considered as medication errors based on no identified clinical reason. Results: A total of 114 patients were included in this study. Over two-thirds of the study patients (73.7%) experienced 215 medication errors identified by a clinical pharmacist conducting medication reconciliation. Most errors were omission (87.9%). Cardiovascular agents followed by NSAID were commonly in error (53%) and (10.2%) respectively. In a logistic regression model, age (odds ratio (OR), 1.055: 95% confidence interval (CI) 1.010 - 1.102), female gender (OR, 3.468: 95% CI 1.232- 9.761) and number of medications at admission (OR, 0.810: 95% CI 0.681-0.963) were predictors for medication history errors at admission. Conclusions: Medication errors at the time of hospital admission are common and undetected.  A structured approach like the LIMM-based medication reconciliation at Iraqi hospital is needed to detect these errors.

O aumento da proporção de idosos trouxe mudanças importantes no perfil de morbidade geral. Uma maior frequência de doenças crônicas faz com que a prescrição de medicamentos seja cada vez mais extensa e mais complexa nesta população. Estes aspectos, somados às variações farmacocinéticas e farmacodinâmicas relacionadas com a idade e à crescente medicalização, levam ao aumento do risco de problemas relacionados à farmacoterapia, tais como o uso de medicamentos potencialmente inapropriados (MPI) e correspondente aparecimento de reações adversas. Esta dissertação tem como objetivo avaliar o uso de MPI entre idosos brasileiros utilizando a Lista PRISCUS (2010). Os dados analisados são provenientes da Pesquisa Nacional de Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM), de caráter transversal e amostra probabilística populacional em municípios brasileiros urbanos. Neste estudo, foram analisadas as informações obtidas com a população de idosos (60 anos ou mais) (N=9.019). A variável independente foram os medicamentos utilizados por idosos com 60 anos ou mais. As variáveis intervenientes foram sexo, idade, escolaridade, nível econômico e região geográfica. Também foram analisadas as variáveis presença de doença crônica e médico que trata doença crônica. Uma análise multivariável foi realizada para identificar os fatores para o uso de medicamentos inapropriados. Do total de idosos, 18,1% utilizaram no mínimo um medicamento considerado potencialmente inapropriado, independente de dose, sendo que o grupo de medicamentos para o sistema nervoso correspondeu a 45,8%, sendo a amitriptilina a mais prevalente. O uso de medicamentos inapropriados foi maior em mulheres (20,4%), idosos com 80 anos ou mais (22,2%), idosos com nenhuma escolaridade (21,5%), nível econômico C (18,6%), região Sul do Brasil (22,4%), idosos com doença crônica (DC) (21,8%) e que tratavam a DC com mais de um médico (28%). De acordo com a análise multivariável, a variável que se mostrou associada à maior probabilidade para o uso de medicamentos inapropriados foi o aumento do número de medicamentos. Idosos que utilizam maior número de medicamentos simultaneamente (polifarmácia) têm maior probabilidade de terapia inapropriada. Com o intenso processo de envelhecimento, a tendência é aumentar a utilização de medicamentos na população. Programas de atenção ao idoso devem constar como prioridade dos órgãos públicos de saúde. / The proportion of aged has increased causing important changes in the general morbidity profile. A higher frequency of chronic diseases makes medications prescription more and more extensive and complex in this population. These aspects, coupled with pharmacokinetic and pharmacodynamic variations related to age and increasing medicalization, lead to an increased risk of problems related to the use of medications, such as the use of potentially inappropriate medications (PIM) and corresponding adverse reactions. This dissertation aims at evaluating the use of PIM among Brazilian elders using the PRISCUS List (2010). The analyzed data came from the National Survey of Access, Use and Promotion of the Rational Use of Medicines (PNAUM, in Portuguese), of transversal character and population probabilistic sample in urban Brazilian municipalities. In this study, the information obtained with the elderly population (60 years or more) (N=9.019) was analyzed. The independent variable was the medication used by the 60 years old people or older. The intervening variables were sex, age, schooling, economic level and geographic region. Also, it were analyzed the presence of chronic disease and the doctor who treats chronic disease. A multivariate analysis was performed to identify the risk factors for the use of inappropriate medications. Of the total aged, 18.1% used at least one medication considered to be potentially inappropriate, regardless of dose, and the group of medications for the nervous system corresponded to 45.8%, with amitriptyline being the most prevalent. The use of inappropriate medications was higher in women (20.4%), 80 years old people or older (22.2%), aged with no schooling (21.5%), economic level C (18.6%), South region of Brazil (22.4%), aged with chronic disease (CD) (21.8%) and who treated CD with more than one physician (28%). According to the multivariate analysis, the variable that was shown to be associated with the greatest probability for the use of inappropriate medications was the increase in the number of medications. Aged who use more medications at the same time are more likely to have inappropriate therapy. With the intense process of aging, the tendency is to increase the use of medications by the population. Aged care programs should be a priority of public health agencies.

Den 1 maj år 2021 infördes lag (2018:1212) om nationell läkemedelslista. Nationella läkemedelslistan (NLL) ska ge en samlad bild av patientens förskrivna och uthämtade läkemedel till hälso-och sjukvården, apoteken och patienten. De berörda aktörerna upplever olika orosmoment kopplade till implementeringen av NLL och det verkar inte finnas någon gemensam, konkret målbild. Studiens syfte är att undersöka upplevelser av och uppfattningar om implementeringen av Nationella läkemedelslistan med hjälp av mjukt systemtänkande. I studien användes tekniker inom Soft Systems Methodology. Som komplement användes kvalitativ innehållsanalys. Tre semistrukturerade gruppintervjuer med 2–5 deltagare, utifrån ett strategiskt urval, från vardera perspektiv myndighet, apotek och vård genomfördes. Från de tre tillfrågade perspektiven finns en samsyn kring att tanken med NLL i grunden är bra, men det finns ingen gemensam bild av när NLL kommer att vara implementerat eller hur det kommer att fungera då. De olika perspektiven har olika förutsättningar för att implementera NLL och har kommit olika långt. Störst utmaningar verkar finnas för vårdperspektiv där den teknik som beskrivs kring NLL ligger långt ifrån de arbetssätt som finns idag och det är oklart hur olika lagar samverkar. Gällande hur det kommer att fungera med NLL i december år 2025 finns en samsyn kring att det kommer att krävas ändrade arbetssätt för att nyttorna med NLL ska kunna realiseras, men uppfattningarna om hur och när det kommer att inträffa divergerar. Det finns uppfattningar om att implementeringen av NLL inte kommer att vara genomförd i december år 2025. Framtidsönskemålen kring NLL skiljer sig också åt mellan de olika perspektiven. Det är inte möjligt att implementera NLL med fokus endast på de tekniska delarna, utan det krävs mer fokus på arbetssätt och hur de påverkas. Det behövs mer forskning kring hur upplevda problem och hinder ska kunna lösas och studier för att utvärdera implementeringen och som mäter resultat och effekter av NLL. / On 1 May 2021, the Act (2018:1212) on the national medication list came into effect. The National Medication List (NLL) is supposed to provide a comprehensive and updated list of the patient's prescribed and dispensed medicines to the healthcare, pharmacies and the patient. The actors concerned experience various concerns linked to the implementation of NLL and there does not seem to be any common, concrete target image. The aim of the study is to explore experiences and perceptions of the implementation of the National Medication List using soft systems thinking. The study used techniques within Soft Systems Methodology. As a complement, qualitative content analysis was used. Three semi-structured group interviews with 2-5 participants, based on a strategic selection, from each perspective of authority, pharmacy and healthcare were carried out. From the three perspectives asked, there is a consensus that the idea of ​​NLL is good in essence, but there is no common picture of when NLL will be implemented or how it will work then. The different perspectives have different prerequisites for implementing NLL and have reached different stages of implementation. The biggest challenges seem to be for the healthcare perspective, where the technology described around NLL is far from the working processes that exist today, and it is unclear how different laws cooperate.  Regarding how it will work with NLL in December 2025, there is a consensus that changed working processes will be required in order for the benefits of NLL to be realized, but perceptions of how and when that will occur diverge. There are perceptions that the full implementation of NLL will not be carried out in December 2025. The future desires regarding NLL also differ between the different perspectives.  It is not possible to implement NLL with solely a technical focus. More focus is required on working processes and how they are affected. More research is needed into how perceived problems and obstacles can be solved and studies to evaluate the implementation and to measure results and effects of NLL are needed too.

Background: Discrepancies in patient’s medication list can lead to medication errors which is a major cause of both morbidity and mortality today. The aim of the study was to examine the frequency of discrepancies in the Swedish prescription list “My saved prescriptions” regarding noncurrent treatment, incorrect dosages, double prescriptions, and missing prescriptions. Additionally, the purpose was to examine the type of source of information the patients used regarding their drug treatment.   Methods: Collection of data was conducted through interviews at three different pharmacies over a period of four weeks in Stockholm 2020. Patients 18 years or older with at least three prescribed drugs were asked to participate in the study.   Results: Of 157 patients, 74 patients were included. More than 70% of the patients had one or more discrepancies in their prescription list: a noncurrent, a duplicate or an incorrect dosage. 17.6% had at least one missing prescription. About half of the patients had a noncurrent prescription, which was the most common discrepancy among the patients. More than a third, 35.1%, of the patients used the prescription list as a source of information for their drug treatments. Furthermore, 31.1% of the patients used the drug packaging and 17.6% of them only used their memory. 10.8% of the patients used the medication list from healthcare.  Conclusions: The results suggest that discrepancies were quite common in the prescription list, which can increase the risk of medication errors for patients who use the prescription list as a source of information. The implementation of the Swedish National List (NLL) (launching in 2021) will provide the caregivers, pharmacies, and patients with access to the same information about patient’s prescribed drugs. NLL will hopefully reduce the risk of medication errors and it should lead to a reduced necessity of using several different sources for prescribed drugs.

Läkare, sjuksköterskor, farmaceuter, patienter och patienters anhöriga är alla delar av den kedja som ska se till så att läkemedelsanvändning sker på ett säkert sätt. Så många inblandade och i så många olika sammanhang gör att läkemedelsanvändning kan vara svårt att hantera. 2014 skrevs det ut 102 913 130 recept i Sverige (1). Fram till 2014 hade ca 850 000 felaktiga recept korrigerats av farmaceuter varje år (2). Att korrigera recept är en nödvändig del som ingår i farmaceutens skyldighet och ansvar vilket regleras i svensk lagstiftning (3). Farmaceuten är en del av vårdkedjan som skall tillse att patienten har en korrekt och säker behandling med läkemedel (4). Tillgång till en nationell gemensam läkemedelslista för alla berörda parter, förskrivare, farmaceut, patient och övrig vårdpersonal skulle kanske kunna komma tillrätta med felaktigheter i förskrivningar och därmed öka patientsäkerheten (4). Tidigare studier har genomförts som behandlar läkarens syn på en gemensam lista och även patientens syn på eHälsoarbete vilket till viss del belyser en gemensam lista (5)(6) men inga studier har hittats om hur en gemensam lista kommer att påverka farmaceuternas vardag vilket ett av syftena med detta arbete har varit. För att uppnå syftet genomfördes en enkätundersökning med farmaceuter verksamma på ett antal apotek där de fick delge sina tankar både kring den information om patienters aktuella läkemedel som finns tillgänglig idag, bland annat genom receptdepån och sina tankar kring en nationell gemensam läkemedelslista. Resultat av undersökning gör gällande att det förekommer fel i receptdepån både med avseende på saknad information, felaktigheter i recept och att recept förekommer mer än en gång och att de finns med trots att patienten inte skall använda dem mer. Majoriteten av farmaceuterna var eniga om att en nationell gemensam läkemedelslista skulle hjälpa dem i deras arbete för att öka patientsäkerheten men huruvida den kommer att lösa alla problem som förekommer i receptdepån får framtiden utvisa. / Doctors, nurses, pharmacists, patients and next of kin are all parts of the chain that is needed to make sure that the use of medication is safe and appropriate for the patient. That many people involved and in many different settings can make the use of medication difficult to manage. In the year 2014 there were 102 913 130 prescriptions made out to patients in Sweden. Up to the year 2014 850 000 corrections had been made to prescriptions with faults in them by pharmacists each year. To correct prescriptions is an essential part of the pharmacist’s obligations and responsibility, a responsibility that is regulated in Swedish law. The pharmacist is the last part of the chain that has the possibility to adjust anything that is wrong with medications and the use of it before it is in the patient’s own hands. The access to a nationally shared medication list for all involved parties might solve some of the problems that faces the responsible parties when it comes to dealing with patients and their new and ongoing medications and in that way be able to increase the safety around mediation for the patient in need. Although the survey conducted as part of this paper focuses on pharmacists the background tries to explain in what way the different professions come in contact with medicines and how they would perhaps benefit from a shared list. The paper also tries to give a little insight to what kind of problems there could be related to prescriptions. In Sweden we have come a rather long way in the use of computers and the use of internet in the field of eHealth compared to other countries. The paper tries to show how the problem surrounding prescription of medicine is handled in the other countries of Scandinavia. Earlier studies have been conducted that looks at shared lists from the doctors view and also studies have been conducted that looks upon eHealth for patients partly in view of shared medication lists. No studies have been found that looks specifically at how pharmacists feel about it and how such a list would benefit them in their work to secure patient safety, hence this paper. In order to reach the papers purpose a survey was performed with pharmacists employed at different pharmacies in the southern part of Sweden. The result of the survey showed that there are indeed problems with prescriptions in the prescription repository and the majority of the pharmacists agreed that a shared medication list could help them in their work to secure patient safety when releasing prescribed medication. Although the pharmacist agreed for the most part in the benefits of such a list they did not know if it would solve all problems, which is for the future to decide.

Background: Medications are used to treat, cure, or relieve symptoms of diseases, but there is a risk with the use of medications. Drug-related-problems are known to increase morbidity and mortality. Incorrect medical list and discrepancies in these lists can lead to drug-related problems as side effects, hospitalization, non-compliance, drug interactions and overtreated or undertreated patients. Discrepancies can be for example: more prescriptions than necessary, outdated prescriptions, i.e., medicines that will not be used, prescriptions with incorrect dosing and missing prescriptions i.e., medicines used by patients that cannot be seen in the medication list. Purpose:  The aim of this study was to investigate discrepancies in the Swedish prescription list "My saved prescriptions at the pharmacy". The secondary aim was to investigate how common it is to use this prescription list or the dosage label on the medicine packaging to know which medicines to use and which dosage. Methods: The data collection was performed by four pharmacy students at seven pharmacies in Sweden over a period of three weeks during Jan-Feb. 2021 where the prescription list was investigated together with patients to identify any discrepancies. The study included patients who was over 18 years old, spoke Swedish, had three or more prescribed drugs, and agreed to participate.  Results A total of 215 patients were interviewed, where 61% had one or more discrepancies in their medication list. A total of 1717 prescriptions were analyzed, of which 10% were double prescriptions (n = 167), 8% outdated prescriptions (n = 141) and 3% prescriptions with the wrong dosage (n = 42). When analyzing the primary sources of information used by patients to know which medicine to use, the printout of the list "my saved prescriptions at the pharmacy” dominated (n = 72).  Most used information source to know drug dosage was the dosage label on the medicine packaging (n = 112). Conclusions: It is important to have an updated and correct information in the medication list, to prevent drug-related-problems caused by discrepancies. It becomes even more important when we see that the medication list "My saved prescriptions at the pharmacy" and dosage label (containing the same information in the medication list), are the most used primary sources by patients to know which drug to use and in what dosage. Finally, results show a relationship between the number of prescribed drugs and the number of discrepancies that occur, and therefore we see more discrepancies in elderly patients who are usually ill and are being treated for several diseases.  There are opportunities for further research to study e.g., which drug-related-problems are caused by discrepancies in the medication list as well as the degree of danger in these problems. / Användning av läkemedel som avses behandla, lindra eller bota sjukdomar kan i vissa fall utgöra en risk för patientens hälsa. Läkemedelsrelaterade problem p.g.a. felmedicinering står för en stor andel av morbiditeten och mortaliteten bland patienter. En bidragande orsak är ofullständig information i patientens läkemedelslista.   Syftet med studien var att undersöka antalet avvikelser som förekommer i receptlistan ”Mina sparade recept på apoteket”. Studiens sekundära syfte var att undersöka vilka informationskällor som användes av patienter för att veta vilka läkemedel som ska adminstreras och i vilken dos dosering.  Studiens metod var att intervjua patienter som kom till apoteket för att hämta ut läkemedel till sig själva och uppfyllde inklusionskriterierna för att delta i studien. Studien utfördes av fyra farmaceutstudenter på sju olika apotek i fyra olika städer i Sverige som tillsammans med patienter gick igenom receptlistan för att identifiera avvikelser.  Resultatet blev totalt 1717 recept som studerades varav 21% hade avvikelser. Av recepten var 10% dubbla recept (n = 167), 8% inaktuella recept (n = 141) och 3% recept med fel dosering (n = 42). Vid analys av primära informationskällor som används dominerade utskrift av listan ”Mina sparade recept på apoteket” (n = 72) resp. doseringsetiketten på läkemedelsförpackningen (n = 112).  Resultaten visade även ett samband mellan ökade antal läkemedel och antalet avvikelser.  Avvikelser i läkemedelslistan Mina sparade recept är vanligt förekommande därmed är listan inte alltid aktuell. Det är vanligt att denna lista och doseringsetikett på läkemedels-förpackningar används som primära källor av patienter under deras behandlingstid vilket kan innebära en risk för läkemedelsrelaterade problem. En gemensam nationell läkemedelslista är en möjlig lösning till att förebygga läkemedelsrelaterade problem orskade av infromationsbrist i läkemedelslistor. Det är dock nödvändigt med läkemedelsgenomgångar för att bibehålla uppdateringen av listan.

Impact on accuracy in elderly patients’ medication list, introducing pharmacy-led medical reconciliation at the Emergency department in a Swedish hospital. Background and objective: Discrepancies in patients‘ medication list is a well-known problem and contribute to preventable medication errors. Medication errors could increase morbidity and mortality and are cost-driving to the Health Care System. The primary objective was to investigate if a pharmacist-led medical reconciliation at the Emergency department could increase the accuracy in medication lists for patients at the age of 75 years and older, with five or more drugs in their initial medication list. The second objective was to categorize the discrepancies and the drugs causing them. Study design: Intervention study with retrospective control group. In the intervention group, patients received a medical reconciliation at the Emergency department. In conformity with the retrospective control group, the intervention group also received a medical reconciliation at the hospital ward. All medical reconciliations where pharmacy-led. Discrepancies identified at the medical reconciliation at the ward, were quantified and categorized. Drugs causing discrepancies were categorized by the ATC-index. Descriptive statistics, Chi2-tests and T-tests were performed.  Setting: The Emergency department at the hospital of Kristianstad, four wards at the larger emergency hospital in Kristianstad and two wards at the smaller local hospital in Hässleholm in Sweden Main outcome measures: Numbers of discrepancies in patients ‘medication list identified at medical reconciliation at hospital ward after having an initial medical reconciliation at the Emergency department (intervention) or not (control). Category of discrepancy and ATC-index of the substance causing the discrepancy. Results: In control group (n=65), 170 discrepancies were identified, on average 2,6 discrepancies/medication list. In intervention group (n=65), corresponding figures were 44 and 0,7 respectively. The difference between the groups was significant (p <0,0001).  The main category of discrepancy was “commission of a medication” in the control group and “route of administration” in the intervention group. Paracetamol was the most common drug to cause discrepancies in the control group, zopiklon and furosemid in intervention group. Conclusion: Pharmacy-led medical reconciliation at the Emergency department significantly reduced the number of discrepancies in patients´medication list.

Submitted by JOSIANE SANTOS DE OLIVEIRA (josianeso) on 2018-08-08T13:48:43Z No. of bitstreams: 1 Fabiane Raquel Motter_.pdf: 88399023 bytes, checksum: 3b609e9bf1fb7252cd2973a8db6869be (MD5) / Made available in DSpace on 2018-08-08T13:48:43Z (GMT). No. of bitstreams: 1 Fabiane Raquel Motter_.pdf: 88399023 bytes, checksum: 3b609e9bf1fb7252cd2973a8db6869be (MD5) Previous issue date: 2018-03-20 / CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível Superior / UNISINOS - Universidade do Vale do Rio dos Sinos / O uso de Medicamentos Potencialmente Inapropriados (MPIs) em idosos pode comprometer a efetividade ou a segurança da farmacoterapia e têm se destacado como importante desafio para saúde pública, visto que está associado a elevados índices de morbidade e mortalidade. Pesquisas nacionais que investigaram esse tema revelam que as prevalências de uso de MPIs variam de 28,0% a 82,6%; contudo, esses estudos utilizaram listas de MPIs validadas na América do Norte e Europa, uma vez que o primeiro consenso brasileiro sobre MPIs foi publicado somente no final de 2016. Segundo os autores, a lista desenvolvida apresenta algumas lacunas no conhecimento, uma vez que foi baseada em critérios publicados até 2012 e, portanto, não inclui as versões mais atualizadas publicadas em 2015, bem como não incorpora possíveis alternativas terapêuticas para os medicamentos que compõem a lista. Dessa forma, este estudo teve como objetivo estabelecer critérios explícitos para avaliação de MPIs prescritos aos idosos no Brasil e suas respetivas alternativas terapêuticas. O projeto englobou duas etapas complementares: 1- Elaboração da lista de critérios explícitos para avaliação de medicamentos inapropriados para idosos a partir de revisão sistemática já realizada; 2- Validação da proposta por consenso de especialistas utilizando técnica Delphi; A primeira etapa, elaboração da lista preliminar de MPIs, foi baseada em um estudo de revisão sistemática das listas publicadas entre janeiro/1991 e abril/2017.Realizou-se também uma análise qualitativa das listas com o objetivo de verificar a aplicabilidade destas ao mercado brasileiro em termos de disponibilidade e frequência de prescrição. Dessa forma, selecionaram-se três listas de MPIs: Beers 2015, STOPP 2015, European Union (7) PIM list. Ao final desse processo, obteve-se 153 critérios distribuídos em sete instrumentos: Dor e Inflamação, Sistema Cardiovascular, Sistema Endócrino, Geniturinário, Sistema Respiratório, Sistema Nervoso Central, sendo os dois primeiros já validados por meio da técnica Delphi modificada. Considerou-se validados os itens para os quais o limite inferior do IC 95% foi superior ou igual a 4,0. O consenso sobre MPIs - Dor e inflamação foi constituído duas rodadas. Um grupo de nove especialistas atingiu consenso sobre 98 (63,2%) das 155 questões apresentadas: 31/34 preocupações independente do diagnóstico, 4/4 preocupações quanto à dose, 4/4 preocupações quanto a duração do tratamento, 19/20 preocupações quanto ao uso em condições específicas, 12/23 considerações especiais de uso e 28/68 alternativas terapêuticas. No consenso sobre MPIs -Sistema Cardiovascular, um grupo de sete especialista atingiu consenso sobre 84 das 257 questões apresentadas: 20/25 preocupações independente do diagnóstico, 4/4 preocupações quanto à dose, 37/57 preocupações quanto ao uso em condições específicas, 20/105 considerações especiais de uso e 3/66 alternativas terapêuticas. Embora a validação de listas de MPIs a partir da opinião de especialistas seja um processo complexo, a listas desenvolvidas poderão ampliar o conhecimento sobre MPIs no país, uma vez que são baseadas em consensos recentes. Desse modo, esta pesquisa possibilitará um melhor entendimento da magnitude do uso de MPIs no Brasil, e poderá contribuir para o desenvolvimento de estratégias e intervenções mais eficazes para a redução dos problemas relacionados ao uso de medicamentos em idosos no país. / The use of potentially inappropriate medications (PIMs) for older patients is a public health problem because it can compromise the effectiveness or safety of pharmacotherapy and is responsible for high rates of morbidity and mortality in this age group. Brazilian studies that investigated PIMs show that the prevalence of PIM use ranges from 28.0% to 82.6%. However, these studies used PIM lists developed in other countries in North America and Europe. The first Brazilian consensus on PIMs was published in 2016. Limitations reported by the authors included that the PIM list was based on previous versions of Beers (2012) and STOPP (2008), therefore, it did not include the most up-to-date versions published in 2015, and did not incorporate therapeutic alternatives. The aim of the present study is to develop and validate explicit criteria for the evaluation of PIMs prescribed to older patients in Brazil and their respective therapeutic alternatives. The development of this project comprises of two steps: 1- Elaboration of the preliminary PIM list for older patients based on a systematic literature review; 2 - Validation of the preliminary PIM list with the consensus of experts using modified Delphi technique; The elaboration of the preliminary list of MPIs was based on a systematic review of PIM lists published between January 1991 and April 2017. A qualitative analysis of the PIM lists was performed with the objective of verifying their applicability to the Brazilian market. This way, three lists of PIMs were selected: Beers’ 2015, STOPP 2015, and European Union (7) PIM. Thus, we obtained 153 explicit criteria distributed across seven instruments: PIMs–Pain and Inflammation, PIMs–Cardiovascular System, PIMs–Endocrine System, PIMs–Genitourinary, PIMs–Respiratory System, and PIMs–Central Nervous System. The first two were already validated using the modified Delphi technique. The items for which the lower limit of the 95% confidence interval (CI) was greater than or equal to 4.0 were considered to have been validated. The consensus on PIMs–Pain and Inflammation was formed by two rounds. A group of nine experts reached consensus on 98 (63.2%) of the 155 items. A consensus was reached for 31/34 concerns regardless of diagnosis, 4/4 dose concerns, 4/4 concerns about the duration of treatment, 19/20 concerns about use under specific conditions, 12/23 special considerations of use, and 28/68 therapeutic alternatives. In the consensus on PIMs–Cardiovascular System, a group of seven experts reached consensus on 84 of the 257 questions. A consensus was reached for 20/25 concerns independent of diagnosis, 4/4 concerns regarding dose, 37/57 concerns regarding use under specific conditions, 20/105 special considerations of use and 3/66 therapeutic alternatives. Although the development and validation of PIM lists based on expert opinion is a long and complex process, the development of PIM list based on recent consensuses will expand the knowledge about the PIMs in Brazil. Thus, this research will improve the understanding of the magnitude of PIM use in this country, and may contribute to the development of more effective strategies and interventions to reduce drug-related problems among older Brazilian patients.